Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Developing connections amongst B lymphocytes and deregulated pathways in autoimmunity.
Interferon beta-1b-induced postmenopausal bleeding in a patient with multiple sclerosis.
Rabies virus-mediated oligodendrocyte labeling reveals a single oligodendrocyte myelinates axons from distinct brain regions.
Alemtuzumab treatment alters circulating innate immune cells in multiple sclerosis.
CD40-Mediated NF-κB Activation in B Cells Is Increased in Multiple Sclerosis and Modulated by Therapeutics.
Five-year Safety Data from 5 Clinical Trials of Subcutaneous Golimumab in Patients with Rheumatoid Arthritis, Psoriatic Arthritis, and Ankylosing Spondylitis.
Neuroendothelial NMDA receptors as therapeutic targets in experimental autoimmune encephalomyelitis.
Adherence and persistence to drug therapies for multiple sclerosis: A population-based study.
Hypofrontality and Posterior Hyperactivity in Early Schizophrenia: Imaging and Behavior in a Preclinical Model.
Frequency of viral infections and environmental factors in multiple sclerosis.
The efficacy and safety of teriflunomide based therapy in patients with relapsing multiple sclerosis: A meta-analysis of randomized controlled trials.
Healthy Aging from the Perspectives of 683 Older People with Multiple Sclerosis.
A new role for the P2Y-like GPR17 receptor in the modulation of multipotency of oligodendrocyte precursor cells in vitro.
Proteomics and transcriptomics of peripheral nerve tissue and cells unravel new aspects of the human schwann cell repair phenotype.
Multiple sclerosis: Successful trial of amiselimod for multiple sclerosis.
Comparison of outcomes between laparotomy and robotic technique for cervical cancer.
Transcranial sonography of subcortical structures in patients with multiple sclerosis.
Striving for Balance Between Caring and Restraint: Young Adults' Experiences with Parental Multiple Sclerosis.
Rethinking the importance of paroxysmal and unusual symptoms as first clinical manifestation of multiple sclerosis: They do matter.
Angiotensin-(1-7) Protects from Brain Damage Induced by Shiga Toxin 2-Producing Enterohemorrhagic Escherichia Coli.
Different etiologies and prognoses of optic neuritis in demyelinating diseases.
Nogo receptor complex expression dynamics in the inflammatory foci of central nervous system experimental autoimmune demyelination.
Inducible gene modification in the gastric epithelium of Tff1-CreERT2, Tff2-rtTA, Tff3-luc mice.
Partial MHC class II constructs as novel immunomodulatory therapy for stroke.
Myelin and oligodendrocyte lineage cells in white matter pathology and plasticity after traumatic brain injury.
Pages
« first
‹ previous
…
845
846
847
848
849
850
851
852
853
…
next ›
last »